Investment Corporation of Bangladesh (DSE:ICB)

Market Cap	41.98B
Revenue (ttm)	2.24B
Net Income (ttm)	209.77M
Shares Out	867.26M
EPS (ttm)	0.24
PE Ratio	200.10
Forward PE	n/a
Dividend	0.20 (0.41%)
Ex-Dividend Date	Dec 8, 2024

Volume	227,825
Average Volume	325,350
Open	48.60
Previous Close	48.40
Day's Range	48.20 - 49.60
52-Week Range	40.00 - 79.90
Beta	0.33
RSI	52.06
Earnings Date	Nov 9, 2025

About Verve Therapeutics

Investment Corporation of Bangladesh, together with its subsidiaries, provides various investment banking services in Bangladesh. The company engages in the investments through private equity and placement of shares; merger and acquisition function; trustee and custodian services; portfolio management; advance against unit funds and Bangladesh fund certificates; stock market operations; project financing through investing in equity, preference share and bonds, and debt and lease financing; and issuing of corporate guarantee, as well as provides...

• Industry: Investors, not elsewhere classified
• Founded: 1976
• Employees: 941
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ICB

Financial Performance

In 2024, DSE:ICB's revenue was 2.15 billion, a decrease of -41.91% compared to the previous year's 3.71 billion. Earnings were 326.77 million, a decrease of -57.88%.